COMMUNIQUÉS West-GlobeNewswire

The Ensign Group Schedules First Quarter 2019 Earnings Call for Tuesday, May 7, 2019
30/04/2019
MISSION VIEJO, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign (TM) group of skilled nursing, rehabilitative care services, assisted living, home health [...]
Amicus Therapeutics Presents Positive Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting
30/04/2019
Preclinical Studies Show Robust Uptake and Glycogen Reduction in Multiple Tissues, Including Brain and Spinal Cord Initial Validation for Collaboration Combining Amicus-Engineered Transgenes with Penn’s AAV Gene Therapy [...]
PCI Biotech: Invitation to first quarter 2019 result presentation
30/04/2019
Oslo, Norway, 30 April 2019 - PCI Biotech invites to a presentation of the company's first quarter 2019 result on Wednesday 8 May 2019 at Oslo Cancer Cluster Innovation Park. Time: Wednesday 8 May, 08:30am – 09:30am [...]
Capital Senior Living Corporation Announces Release Date for First Quarter 2019 Financial Results
30/04/2019
DALLAS, April 30, 2019 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (NYSE:CSU) will host a conference call with senior management to discuss the Company’s first quarter 2019 financial results. The call will be [...]
Oncology Venture provides news on its clinical development projects dovitinib, 2X‑121 and LiPlaCis
30/04/2019
Press release Hørsholm, Denmark and Cambridge, MA, US, April 30, 2019 – Oncology Venture A/S today provides news on DRP ® based analyses of biopsies from clinical trials with dovitinib. In addition to renal, endometrial [...]
Saniona publishes the Annual Report for 2018
30/04/2019
PRESS RELEASE April 30, 2019 Saniona (OMX: SANION), a biotech company focused on the treatment of eating disorders and diseases of the central nervous system, announced today that the English version of the Annual [...]
BrainStorm’s Cellular Technology Platform Expanded to Include Exosomes for Neurodegenerative Diseases
30/04/2019
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Brainstorm-Cell Therapeutics Inc. , ( NASDAQ: BCLI ), a leading developer of adult stem cell therapeutics for neurodegenerative disease, today announced that it has expanded [...]
Solo Growth Corp™ Announces Fourth Quarter and Year End 2018 Results and Recent Operational Highlights
30/04/2019
CALGARY, Alberta, April 29, 2019 (GLOBE NEWSWIRE) -- Solo Growth Corp.™ (the “ Company ” or “ Solo Growth ”) (TSXV: SOLO) (WKN:A2PBMC), a cannabis retailer operating as YSS™ with the vision to become a premier retailer [...]
Helix BioPharma Corp. Closes Second Tranche of Private Placement
30/04/2019
RICHMOND HILL, Ontario, April 29, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Eye Consultants of Northern Virginia, PC Pleased to Welcome Leah Fuchs, MD
29/04/2019
SPRINGFIELD, Va., April 29, 2019 (GLOBE NEWSWIRE) -- Eye Consultants of Northern Virginia, PC is pleased to welcome Leah Fuchs, MD to their practice. Dr. Fuchs is a board-certified ophthalmologist who specializes in [...]
XORTX Provides Overview and Announces $5 Million Financing to Advance Clinical Trials
29/04/2019
Pivotal Registration Clinical Study with XRx-008 and Phase 2b Clinical Study withTMX-049 Planned in 2020 CALGARY, Alberta, April 29, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: [...]
TCR2 Therapeutics Announces First Quarter 2019 Earnings Conference Call and Webcast
29/04/2019
Earnings to be released after market close on Monday, May 13, 2019 CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (TCR 2 ) (Nasdaq: TCRR), a clinical-stage immunotherapy company developing [...]
Avadel Pharmaceuticals to Report First Quarter 2019 Financial Results
29/04/2019
DUBLIN, Ireland, April 29, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for sleep disorders, today announced that it will host a conference call and live [...]
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
29/04/2019
WALTHAM, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced that it has commenced an underwritten public offering of $175,000,000 in shares of its common stock. In addition, [...]
Novan Secures Up to $35 Million in Non-Dilutive Funding
29/04/2019
$25 million provided immediately in exchange for participation in future potential cash flows Additional $10 million available upon achieving success in molluscum Phase 3 top line results Pipeline Priority: initiation [...]
Precision BioSciences Reports First Quarter 2019 Financial Results
29/04/2019
DURHAM, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, a genome editing company dedicated to improving life (Nasdaq: DTIL) (“Precision”) through the application of its proprietary ARCUS genome editing [...]
Alimera Sciences Announces First Quarter 2019 Financial Results and Provides Corporate Overview
29/04/2019
First Quarter and Recent Company Highlights: Global revenue up 34% versus Q1 2018 Regulatory approval obtained for ILUVIEN ® in 17 EU countries for the treatment of Non-Infectious Posterior Uveitis Samer Kaba, M.D. [...]
Otonomy to Report First Quarter 2019 Financial Results and Provide Corporate Update
29/04/2019
Webcast and Conference Call to be Held at 4:30 p.m. EDT on May 6, 2019 SAN DIEGO, April 29, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative [...]
Silk Road Medical to Report First Quarter 2019 Financial Results on May 8, 2019
29/04/2019
SUNNYVALE, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results [...]

Pages